Listen here, or download the 34 MB mp3 file.
Medical innovation continues to flourish, however entrepreneurs are faced with many challenges, including tougher regulatory demands which make it more difficult to get products to market. This panel discussion includes representatives from various investment firms who give a clearer picture of the funding landscape, advising early stage innovators with creative ways to navigate these complexities. From the 2011 Global Health Series organized by the Stanford Global Health Center in partnership with the Stanford Graduate School of Business, Stefanos Zenios, the Charles A. Holloway Professor and director of the Stanford GSB’s Program in Healthcare Innovation leads this panel which convenes Anne DeGheest of MedStars Venture Partners, Thomas McKinley of Cardinal Partners, Guido Neels of Essex Woodlands, Bryan Roberts of Venrock, and Beth Seidenberg of Kleiner Perkins Caufield & Byers.
Substitute the word “impact” for “social performance,” and current debates in the investment community sound exactly like the ones the microfinance industry had 10 years ago. The investor community can learn from microfinance’s successful efforts to set standards for non-financial returns—the “other bottom line.”